APP
ETNB

Alpha Paradigm Partners’s 89bio ETNB Stock Holding History

Alpha Paradigm Partners’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$858K Buy
+67,433
New +$607K 0.35% 88

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Alpha Paradigm Partners's ETNB Position: Q4 2022 in Review

Alpha Paradigm Partners opened a new position in 89bio (ETNB) in Q4 2022: 67,433 shares worth $858K. The stake represents 0.35% of the portfolio and ranks #88 among its holdings.

106 funds tracked by Wall St. Rank hold ETNB as of Q4 2022.

  • Alpha Paradigm Partners held 67,433 shares of 89bio worth $858K as of Q4 2022.
  • 89bio was a new Alpha Paradigm Partners position in Q4 2022.
  • 89bio made up 0.35% of Alpha Paradigm Partners's portfolio in Q4 2022, its #88 holding.
  • 106 funds tracked by Wall St. Rank held 89bio as of Q4 2022.

Based on Alpha Paradigm Partners's 13F filing for Q4 2022, filed 13 Feb 2023.